2017 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
October 6, 2017 - Edge Therapeutics to Present at the Neurocritical Care Society 15th Annual Meeting
Read More
September 20, 2017 - Edge Therapeutics to Present at Upcoming Investor Conferences
Read More
September 19, 2017 - Edge Therapeutics Appoints Rosemary A. Crane, Pharmaceutical Industry Leader, to its Board of Directors
Read More
August 1, 2017 - Edge Therapeutics Reports Second Quarter 2017 Financial Results and Continued Operational Progress
Read More
July 18, 2017 - Edge Therapeutics Announces Second Quarter Financial Results Conference Call on August 1, 2017
Read More
July 6, 2017 - Edge Therapeutics Announces Commercial Supply Agreement for EG-1962 with Oakwood Laboratories
Read More
June 15, 2017 - Edge Therapeutics to Participate in the JMP Securities Life Science Conference
Read More
June 8, 2017 - Edge Therapeutics Receives Pediatric Investigation Plan Waiver from the European Medicines Agency
Read More
June 2, 2017 - Edge Therapeutics to Present at Jefferies 2017 Global Healthcare Conference
Read More
May 10, 2017 - Edge Therapeutics to Present at Bank of America Merrill Lynch 2017 Health Care Conference
Read More
May 3, 2017 - Edge Therapeutics Reports First Quarter 2017 Financial Results and Continued Operational Progress
Read More
April 21, 2017 - Edge Therapeutics Announces Conference Call on May 3, 2017 to Discuss First Quarter 2017 Financial Results
Read More
April 19, 2017 - Edge Therapeutics Announces $18 Million Registered Direct Offering of Common Stock
Read More
March 29, 2017 - Edge Therapeutics to Present at Needham & Company’s 16th Annual Healthcare Conference
Read More
March 13, 2017 - Edge Therapeutics Announces First Patient Randomized in Study of Intracisternal Administration of EG-1962 in Adults with Aneurysmal Subarachnoid Hemorrhage
Read More
March 3, 2017 - Edge Therapeutics to Present at Cowen and Company 37th Annual Healthcare Conference on March 8, 2017
Read More
March 2, 2017 - Edge Therapeutics Reports Fourth Quarter and Full Year 2016 Financial Results
Read More
February 23, 2017 - Edge Therapeutics Announces Conference Call on March 2, 2017 to Discuss Fourth Quarter and Full Year 2016 Financial Results
Read More
February 21, 2017 - Edge Therapeutics Appoints Alyssa Wyant as Senior Vice President, Regulatory Affairs and Makes Inducement Grant under NASDAQ Rule 5635(c)(4)
Read More
February 17, 2017 - Edge Therapeutics’ EG-1962 Data To Be Presented at International Stroke Conference 2017
Read More
February 8, 2017 - Edge Therapeutics to Present at Investor Conferences in February
Read More

Printer Friendly Version Print PageE-mail this page Email PageRSS RSS FeedsE-mail Alerts Email AlertsView contacts IR Contacts